( 7.1 ) • Thalidomide: Increased risk of renal dysfunction in patients with multiple myeloma. 7.2 Thalidomide In multiple myeloma patients, the risk of renal deterioration may be increased when pamidronate disodium is used in combination with thalidomide.
Source: FDA drug label - pamidronate disodium